The Anxiety Disorders Center at Hartford Hospital/Institute of Living is conducting research on a new way to treat panic disorder.
These two studies are open to adults, ages 18-65, who have panic disorder. Participants in the ongoing studies will receive free Cognitive-Behavioral Therapy (CBT), one of the most effective treatments for panic disorder. The studies examine whether a medication, (either an FDA approved antibiotic, D-Cycloserine, in one study, or a medication that has not yet been FDA approved, but has been thoroughly tested for the second study), will improve how well CBT works given in low dosages one to two hours before each therapy session. Previous, smaller studies have shown that certain medications may increase people’s ability to remember and use the strategies learned in therapy and thus may enhance the therapy process.
Participants in these treatment studies are randomly assigned (like a coin toss) to receive either the medication or a placebo pill (sugar pill) in addition to CBT. In these studies we will also examine genetic markers that may be associated with panic disorder. A small blood sample will be drawn from each participant to use for this testing. The information from this sample, as well as the treatment, will be kept confidential.
|
|
|